Clinical Manual for Management of the HIV-Infected ... - myCME.com
Clinical Manual for Management of the HIV-Infected ... - myCME.com
Clinical Manual for Management of the HIV-Infected ... - myCME.com
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Patient Education<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
Patients should know that although <strong>the</strong>y have <strong>the</strong><br />
TB germ in <strong>the</strong>ir bodies, <strong>the</strong>y cannot pass <strong>the</strong> germ<br />
to o<strong>the</strong>rs while TB is latent. However, because <strong>the</strong>y<br />
have <strong>HIV</strong> infection, <strong>the</strong> TB germ is more likely to<br />
make <strong>the</strong>m sick at some point in <strong>the</strong> future.<br />
The medicine patients are starting will help kill <strong>the</strong><br />
TB germ and reduce <strong>the</strong>ir chances <strong>of</strong> getting sick<br />
with active TB.<br />
Patients must take all <strong>of</strong> <strong>the</strong>ir medicine, every day,<br />
to prevent <strong>the</strong> TB germ from spreading and making<br />
<strong>the</strong>m sick.<br />
If patients have adverse effects, such as rash or<br />
itching, tell <strong>the</strong>m to contact <strong>the</strong>ir health care<br />
providers immediately. Occasionally, INH can cause<br />
tingling or numbness in <strong>the</strong> hands or feet. The<br />
pyridoxine (vitamin B6) <strong>the</strong>y are taking should help<br />
prevent that, but <strong>the</strong>y should let <strong>the</strong>ir providers know<br />
if it occurs.<br />
Patients should avoid alcohol while taking <strong>the</strong>se<br />
medications. The medicines <strong>for</strong> TB are processed<br />
by <strong>the</strong> liver and, when <strong>com</strong>bined with alcohol,<br />
<strong>the</strong>y easily can overload <strong>the</strong> liver. Acetaminophen<br />
(Tylenol) also is processed by <strong>the</strong> liver, so patients<br />
should keep <strong>the</strong>ir intake to a minimum. (Patients<br />
with hepatitis C, liver disease, or chronic alcohol use<br />
should not take more than 3.5 grams per day.)<br />
Blood tests will be done regularly to make sure <strong>the</strong><br />
liver is working well, so it is important <strong>for</strong> patients to<br />
keep <strong>the</strong>ir follow-up appointments. They should take<br />
all <strong>the</strong>ir medications, vitamins, and supplements with<br />
<strong>the</strong>m to <strong>the</strong> clinic so that <strong>the</strong>ir health care providers<br />
can review <strong>the</strong>m and make sure <strong>the</strong>re are no drug<br />
interactions.<br />
If patients experience nausea, vomiting, poor<br />
appetite, or abdominal pain, if <strong>the</strong>y notice <strong>the</strong>ir urine<br />
darkening or be<strong>com</strong>ing cola-colored, or if <strong>the</strong>y notice<br />
<strong>the</strong>ir eyes or skin yellowing, <strong>the</strong>y should return to <strong>the</strong><br />
clinic immediately. These problems may indicate that<br />
<strong>the</strong> liver is being overwhelmed, and it is important to<br />
find out be<strong>for</strong>e permanent damage is done.<br />
Rifampin will cause sweat, tears, urine, and plastic<br />
contact lenses to turn orange.<br />
Rifampin will make birth control pills ineffective.<br />
Patients should use a backup method <strong>of</strong><br />
contraception until treatment is <strong>com</strong>plete. Condoms<br />
can help prevent <strong>HIV</strong> transmission and reduce <strong>the</strong><br />
risk <strong>of</strong> pregnancy.<br />
Section 2—Health Maintenance and Disease Prevention | 2–43<br />
References<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
♦<br />
American Thoracic Society. Targeted tuberculin testing<br />
and treatment <strong>of</strong> latent tuberculosis infection. MMWR<br />
Re<strong>com</strong>m Rep. 2000 Jun 9;49(RR-6):1-51.<br />
Blumberg HM, Leonard MK, Jasmer RM. Update<br />
on <strong>the</strong> treatment <strong>of</strong> tuberculosis and latent tuberculosis<br />
infection. JAMA. 2005 Jun 8;293(22):2776-84.<br />
Bucher HC, Griffith LE, Guyatt GH, et al. Isoniazid<br />
prophylaxis <strong>for</strong> tuberculosis in <strong>HIV</strong> infection: a metaanalysis<br />
<strong>of</strong> randomized controlled trials. AIDS. 1999<br />
Mar 11;13(4):501-7.<br />
Centers <strong>for</strong> Disease Control and Prevention,<br />
American Thoracic Society. Update: adverse event<br />
data and revised American Thoracic Society/CDC<br />
re<strong>com</strong>mendations against <strong>the</strong> use <strong>of</strong> rifampin and<br />
pyrazinamide <strong>for</strong> treatment <strong>of</strong> latent tuberculosis<br />
infection—United States, 2003. MMWR Morb<br />
Mortal Wkly Rep. 2003 Aug 8;52(31):735-9.<br />
Leinhardt C, Fielding K, Sillah J, et al. Risk factors <strong>for</strong><br />
tuberculosis infection in sub-Saharan Africa: a contact<br />
study in The Gambia. Am J Respir Crit Care Med.<br />
2003 Aug 15;168(4):448-55.<br />
Quigley MA, Mwinga A, Hosp M, et al. Long-term<br />
effect <strong>of</strong> preventive <strong>the</strong>rapy <strong>for</strong> tuberculosis in a cohort<br />
<strong>of</strong> <strong>HIV</strong>-infected Zambian adults. AIDS. 2001 Jan<br />
26;15(2):215-22.<br />
U.S. Department <strong>of</strong> Health and Human Services.<br />
Guidelines <strong>for</strong> <strong>the</strong> Use <strong>of</strong> Antiretroviral Agents in <strong>HIV</strong>-<br />
1-<strong>Infected</strong> Adults and Adolescents. October 10, 2006.<br />
Available online at aidsinfo.nih.gov/Guidelines/<br />
GuidelineDetail.aspx?GuidelineID=7. Accessed July<br />
7, 2007.<br />
U.S. Public Health Service, Infectious Diseases<br />
Society <strong>of</strong> America. Guidelines <strong>for</strong> preventing<br />
opportunistic infections among <strong>HIV</strong>-infected persons<br />
— 2002. MMWR Re<strong>com</strong>m Rep. 2002 Jun<br />
14;51(RR08);1-46. Available online at aidsinfo.nih.<br />
gov/Guidelines/. Accessed May 19, 2006.